Skip to main content

Ala-Scalp

Generic: Hydrocortisone

Verified·Apr 23, 2026
Manufacturer
Crown Laboratories
NDC
77052-010
RxCUI
197784
Route
TOPICAL
ICD-10 indication
L30.9

Affordability Check

How much will you actually pay for Ala-Scalp?

In 30 seconds, see every legitimate way to afford Ala-Scalp — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About Ala-Scalp

What is this medication?

Ala-Scalp is a topical prescription medication that contains hydrocortisone, which belongs to a class of drugs known as corticosteroids. It is primarily used to treat various inflammatory conditions of the scalp, providing relief from symptoms such as redness, itching, and swelling. By reducing the activity of chemicals in the body that cause inflammation, the medication helps to soothe the skin and decrease discomfort associated with persistent irritation.

This medication is commonly prescribed for skin disorders like seborrheic dermatitis, psoriasis, and eczema that affect the scalp area. It works by suppressing the local immune response and narrowing blood vessels to reduce localized swelling and redness. Because it is a steroid treatment, it should be used exactly as directed by a healthcare professional to avoid potential thinning of the skin or other complications from excessive application.

Copay & patient assistance

  • Patient Copay Amount: Not Publicly Available
  • Maximum Annual Benefit Limit: Not Publicly Available
  • Core Eligibility Restrictions: Not Publicly Available
  • RxBIN, PCN, and Group numbers: Not Publicly Available

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Prescribing information

From the FDA-approved label for Ala-Scalp. Official source: DailyMed (NLM) · Label effective Jan 8, 2025

Indications and usage
INDICATIONS AND USAGE Hydrocortisone Lotion is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Dosage and administration
DOSAGE AND ADMINISTRATION Topical corticosteroids are generally applied to the affected area as a thin film from two to four times daily depending on the severity of the condition. Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions. If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted.
Contraindications
CONTRAINDICATIONS Hydrocortisone Lotion is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.
Warnings and precautions
Rx Only For external use only Not for opthalmic use
Adverse reactions
ADVERSE REACTIONS The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an aproximate decreasing order of occurrence: burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermitis, allergic contact dermatis, maceration of the skin, secondary infection, skin atrophy, striae, and miliaria. To report SUSPECTED ADVERSE REACTIONS, contact Derm Ventures, LLC at 1-833-972-1100 or FDA at 1-800-FDA-1088 or https://fda.gov/Safety/MedWatch/
Use in pregnancy
Pregnancy Category C Corticosteroids are generally teratogenic in laboratory animals when administered systemically at relatively low dosage lavels. The more potent corticosteroids have been shown to be teratogenic after dermal application in laboratory animals. There are no adequate and well-controlled studies in pregnant women on teratogenic effects from topically applied corticosteroids. Therefore, topical corticosteroids should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Drugs of this class should not be used extensively on prenant patients, in large amounts, or for prolonged periods of time.

Label text is reproduced as-is from the FDA-approved label. We do not paraphrase, summarize, or omit. Content above is for informational purposes only and is not medical advice. Always consult your prescribing clinician or pharmacist before making decisions about your medication.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Medicare Part D coverage

How Ala-Scalp appears across Medicare Part D plan formularies nationally. Source: CMS monthly Prescription Drug Plan file (2026-04-30).

Covered by plans

1%

29 of 5,509 plans

Most common tier

Tier 1

On 50% of covering formularies

Prior authorization required

0%

of covering formularies

TierFormularies on this tierShare
Tier 1 (preferred generic)5
50%
Tier 2 (generic)1
10%
Tier 3 (preferred brand)2
20%
Tier 4 (non-preferred brand)2
20%

Step therapy: 0% of formularies

Quantity limits: 0% of formularies

Coverage breadth: 10 of 65 formularies

How to read this:plans on the same formulary share tier + PA rules. Your specific plan's copay depends on (a) the tier above, (b) your plan's cost-share for that tier, (c) whether you're in the initial coverage phase or past the 2026 $2,000 out-of-pocket cap. For your exact plan, check its Summary of Benefits or log in to your Medicare.gov account. Copay cards don't apply to Medicare (federal law).

Prior authorization & coverage

PayerPAStep therapyCopay tier

Medicare Part D

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.